Showing results (1-10 of 5,135) with videos related to

Sort By:
Pageof 514
Diabetes, Obesity & Metabolism|October 18, 2014
Is insulin the most effective injectable antihyperglycaemic therapy?J B Buse, A Peters, D Russell-Jones, et al.
Diabetes, Obesity & Metabolism|January 12, 2012
GLP-1 based therapies: differential effects on fasting and postprandial glucoseM S Fineman, B B Cirincione, D Maggs, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 3, 2015
Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trialsD Russell-Jones, M-A Gall, M Niemeyer, et al.
Diabetes, Obesity & Metabolism|April 19, 2012
Effects of HbA1c and weight reduction on blood pressure in patients with type 2 diabetes mellitus treated with exenatide*S Paul, J Best, K Klein, et al.
EDTNA/ERCA Journal (English Ed.)|October 1, 1996
Encouraging environmental awareness in renal unitsS Furber
Diabetes, Obesity & Metabolism|June 28, 2012
Comparison of safety and tolerability with continuous (exenatide once weekly) or intermittent (exenatide twice daily) GLP-1 receptor agonism in patients with type 2 diabetesT Ridge, T Moretto, L MacConell, et al.
Primary Care|October 16, 1999
The use of insulin alone and in combination with oral agents in type 2 diabetesJ B Buse
Clinical Cornerstone|February 22, 2000
Management of glycemia in type 2 diabetesJ B Buse
International Journal of Clinical Practice|August 19, 2010
The safety and tolerability of GLP-1 receptor agonists in the treatment of type-2 diabetesD Russell-Jones
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|August 13, 2004
Insulin detemir: improving the predictability of glycaemic controlD Russell-Jones
Pageof 514